HomeProductsBuilding BlocksCarbocyclic ScaffoldsBenzene CompoundsTrimebutine
Chemical structure of CAS 39133-31-8

Trimebutine

CAS No.39133-31-8
MDL No.MFCD00133873
MFC22H29NO5
MW387.50
InChI KeyLORDFXWUHHSAQU-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

3,4,5-Trimethoxybenzoic acid [2-(dimethylamino)-2-phenylbutyl] ester is a trihydroxybenzoic acid.

CAS No.39133-31-8
Product NameTrimebutine

Associated Conditions

gastrointestinal disease·irritable bowel syndrome
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Oesophageal motility disorders.

Lancet (London, England) • Vol. 359, Issue 9301 • 2002
PMID: 11809295DOI: 10.1016/S0140-6736(02)07354-3

Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits.

The Journal of pharmacology and experimental therapeutics • Vol. 300, Issue 3 • 2002
PMID: 11861799DOI: 10.1124/jpet.300.3.925

[Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica • Vol. 119, Issue 3 • 2002
PMID: 11915521DOI: 10.1254/fpj.119.185

Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.

Hepato-gastroenterology • Vol. 49, Issue 43 • 2002
PMID: 11941952

Documentation

Similar Products